After coming across few death cases due to Novartis AG's multiple-sclerosis drug Gilenya, the European Medical Agency (EMA) has started an investigation which would see its pros and cons. The EMA said that the main reason to conduct the review is to make sure that the drug is safe.

It has recently been revealed that Paula Deen, a famous name in Southern Cooking, is all set to reveal to the world that she has Type 2 diabetes. It has been confirmed according to reports that Paula is soon going to be seen endorsing a new diabetes control drug made by Novartis Drug Company.

It has been recently said by the US Food and Drug Administration (FDA) authorities that drugs like Percocet, which are addictive in nature, may now be included in the new drug mix up plan by Novartis. They are of the warning that this might be the potential reason for a terrible drug mix up.

The Food and Drug Administration has recently issued a warning over contamination of some of the drugs from Novartis. Following the warning, Novartis has issued a recall of 1,645units of its Excedrin, NoDoz, Bufferin and Gas-X medicines.

Swiss drug manufacturer Novartis AG’s cancer pill Gleevec has now extended the lives of patients with a type of gastrointestinal cancer over the long-term when they took to the drug for three years after the surgery as compared with the commonly used regimen of just a single year.

Finally, the U. S. Food and Drug Administration has given a green signal to Novartis AG's cancer drug Afinitor for a rare type of pancreatic cancer which currently has very few treatment options.

Switzerland-based drug maker, Novartis AG saw sales rise of 14% to $14.03 billion due to its completion of the buyout of the US-based eye care company Alcon and the recent strong demand for a number of its drugs. Its new pill for multiple sclerosis exceeded the expectations forecasted for its first quarter sales.

Novartis, makers of the kidney cancer drugs Everolimus, has proposed a lower price than the initial 2,822 a pack, equivalent to £34,235 a year, which they have not revealed but claim to be discussing with the Department of Health.

Crushing the dreams of the pharmaceutical giant Novartis AG, the US Food and Drug Administration (FDA) has scraped away the company’s launch for Indacaterol, a drug meant for curing lungs related ailments.

The bosses at the FDA have asked for the extended period of three months to go through the findings of the clinical trial that involved indacaterol.

Multiple Sclerosis treatment is bound to revolutionize in Canada as drug-maker Novartis Pharmaceutical Canada Inc. announced on Thursday that the first oral medicine for the condition has been approved for use by some patients in the country. The medication will basically help in providing treatment for the symptoms of MS.